GLP-1 receptor agonists should be rigorously tested as longevity therapeutics

Nature Health 2026

View at publisher

Authors: Nicola Marino, Matteo Fiore, Alex Zhavoronkov

DOI: 10.1038/s44360-026-00109-x

Cited by: 1

References: 13

Fields of Study & Subjects

Diabetes Treatment and Management Genetics Aging and Longevity in Model Organisms Diabetes Cardiovascular Risks and Lipoproteins

References 13